Pharmacological interventions for people with borderline personality disorder-Reference-Cited by-同舟云学术

Pharmacological interventions for people with borderline personality disorder

Published:2022-11-14 Issue:11 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Stoffers-Winterling Jutta M¹,Storebø Ole Jakob²³⁴,Pereira Ribeiro Johanne²⁴,Kongerslev Mickey T⁴⁵,Völlm Birgit A⁶,Mattivi Jessica T¹,Faltinsen Erlend²,Todorovac Adnan²,Jørgensen Mie S²,Callesen Henriette E²,Sales Christian P⁷⁸,Schaug Julie Perrine⁹,Simonsen Erik¹⁰,Lieb Klaus¹

Affiliation:

1. Department of Psychiatry and Psychotherapy; University Medical Center Mainz; Mainz Germany

2. Psychiatric Research Unit; Psychiatry Region Zealand; Slagelse Denmark

3. Child and Adolescent Psychiatric Department; Region Zealand; Roskilde Denmark

4. Department of Psychology; University of Southern Denmark; Odense Denmark

5. District Psychiatric Services Roskilde; Region Zealand Mental Health Services; Roskilde Denmark

6. Department of Forensic Psychiatry, Center for Neurology; University Rostock; Rostock Germany

7. Duncan MacMillan House; Nottinghamshire Healthcare NHS Foundation Trust; Nottingham UK

8. Institute of Mental Health; Department of Psychiatry & Applied Psychology; Nottingham UK

9. Region Zealand Psychiatry; Center for Evidence Based Psychiatry; Slagelse Denmark

10. Research Unit, Mental Health Services, Copenhagen University Hospital; Psychiatry Region Zealand; Roskilde Denmark

Publisher

Wiley

Subject

Pharmacology (medical)

Reference344 articles.

1. Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial;Amminger;Canadian Journal of Psychiatry [Revue Canadienne de Psychiatrie],2013

2. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial;Amminger;Archives of General Psychiatry,2010

3. Verkes Borderline Study: the effect of quetiapine on borderline personality disordered patients clinicaltrials.gov/ct2/show/NCT00254748

4. P.3.c.038. The effect of quetiapine on psychotic-like symptoms in borderline personality disorder. A placebo-controlled trial;Van den Broek;European Neuropsychopharmacology,2008

5. Omega-3 fatty acids associated with valproate in the treatment of borderline personality disorder: a controlled study;Bellino;Journal of Psychopathology,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing psychopharmacological prescribing practices in a large cohort of adolescents with borderline personality disorder;Borderline Personality Disorder and Emotion Dysregulation;2024-08-06

2. Tratamento farmacológico do transtorno de personalidade limítrofe: revisão crítica da literatura e desenvolvimento de algoritmos;Journal Archives of Health;2024-08-05

3. Pharmacological management of personality disorders: from evidence to practice;BJPsych Advances;2024-08-01

4. Systematic Review of the Effectiveness and Experiences of Treatment for Men With Borderline Personality Disorder;American Journal of Men's Health;2024-07

5. Le « Good Psychiatric Management-Adolescents » (GPM-A) : un modèle généraliste et accessible de traitement du trouble de la personnalité borderline chez l’adolescent;Neuropsychiatrie de l'Enfance et de l'Adolescence;2024-07